logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Catabasis Pharmaceuticals, Inc.


USPTO Granted Patents = 29

% Expired Patents = 86.2



Trademarks = 1

Forward Citations = 151

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Michael R Jirousek (29 out of 37 patents)

silverMedal Jill C Milne (28 out of 37 patents)

bronzeMedal Jean E Bemis (27 out of 51 patents)

4.  Chi B Vu (22 out of 43 patents)

5.  Jesse J Smith (9 out of 9 patents)

6.  Amal Ting (4 out of 5 patents)

7.  Allison Wensley (1 out of 1 patent)

8.  R Michael Jirousek (0 patent)

9.  C Jill Milne (0 patent)

10.  J Jesse Smith (0 patent)

11.  E Jean Bemis (0 patent)


Core Competencies:
Fatty Acid
Cysteamine
Niacin
Salicylates
Acetylated
Fumarate
COX Inhibitors
Guanidine
Statin
FXR Agonists
Lenalidomide
Lipoic Acid

29 patents:

1. 10251845 - Fatty acid cysteamine conjugates and their use as activators of autophagy (2019-04-09),
2. RE46608 - Fatty acid niacin conjugates and their uses (2017-11-13),
3. RE46605 - Fatty acid niacin conjugates and their uses (2017-11-13),
4. 9708245 - Fatty acid acylated salicylates and their uses (2017-07-18),
5. 9486534 - Niacin conjugated fatty acid mixtures and their uses (2016-11-08),
6. 9458094 - Fatty acid acetylated salicylates and their uses (2016-10-04),
7. 9289503 - Fatty acid fumarate derivatives and their uses (2016-03-22),
8. 9278136 - Fatty acid niacin conjugates and their uses (2016-03-08),
9. 9272984 - Fatty acid acetylated salicylates and their uses (2016-03-01),
10. 9238077 - Fatty acid niacin conjugates and their uses (2016-01-19),
11. 9216224 - Fatty acid COX inhibitor derivatives and their uses (2015-12-22),
12. 9150504 - Fatty acid guanidine and salicylate guanidine derivatives and their uses (2015-10-06),
13. 9139516 - Fatty acid acetylated salicylates and their uses (2015-09-22),
14. 9085527 - Fatty acid acylated salicylates and their uses (2015-07-21),
15. 9084826 - Fatty acid conjugates of statin and FXR agonists; compositions and method of uses (2015-07-21),
Company Overview
Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, MA, focused on developing innovative therapies for rare diseases and conditions with significant unmet medical needs. The company specializes in advancing its proprietary drug development platform, which employs a unique approach to target the underlying mechanisms of disease. Catabasis is dedicated to improving patient outcomes through its research in areas such as metabolic and neuromuscular disorders, leveraging its expertise in biochemistry and pharmacology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Catabasis Pharmaceuticals, Inc. USPTO Patent Assignee Logo
29 Patents

#93 in Cambridge, MA

#696 in Massachusetts

#11,625 in US

#22,552 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Catabasis Pharmaceuticals, Inc.

Forward Citations = 151

7 inventors:

goldMedal Michael R Jirousek (29 out of 37 patents)

silverMedal Jill C Milne (28 out of 37 patents)

bronzeMedal Jean E Bemis (27 out of 51 patents)

4.  Chi B Vu (22 out of 43 patents)

5.  Jesse J Smith (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Catabasis Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/catabasis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…